FI893683A0 - Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö - Google Patents

Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö

Info

Publication number
FI893683A0
FI893683A0 FI893683A FI893683A FI893683A0 FI 893683 A0 FI893683 A0 FI 893683A0 FI 893683 A FI893683 A FI 893683A FI 893683 A FI893683 A FI 893683A FI 893683 A0 FI893683 A0 FI 893683A0
Authority
FI
Finland
Prior art keywords
isolated dna
human papillomavirus
papillomavirus type
hpv
tumors
Prior art date
Application number
FI893683A
Other languages
English (en)
Swedish (sv)
Other versions
FI893683A (fi
FI98467B (fi
FI98467C (fi
Inventor
Villiers Ethel-Michele De
Anja Hirsch-Behnam
Hausen Harald Zur
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of FI893683A0 publication Critical patent/FI893683A0/fi
Publication of FI893683A publication Critical patent/FI893683A/fi
Publication of FI98467B publication Critical patent/FI98467B/fi
Application granted granted Critical
Publication of FI98467C publication Critical patent/FI98467C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Silicon Polymers (AREA)
  • Enzymes And Modification Thereof (AREA)
FI893683A 1988-08-06 1989-08-03 Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö FI98467C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3826793 1988-08-06
DE3826793A DE3826793A1 (de) 1988-08-06 1988-08-06 Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine

Publications (4)

Publication Number Publication Date
FI893683A0 true FI893683A0 (fi) 1989-08-03
FI893683A FI893683A (fi) 1990-02-07
FI98467B FI98467B (fi) 1997-03-14
FI98467C FI98467C (fi) 1997-06-25

Family

ID=6360384

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893683A FI98467C (fi) 1988-08-06 1989-08-03 Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö

Country Status (9)

Country Link
US (3) US5187090A (fi)
EP (1) EP0354440B1 (fi)
JP (1) JP3016794B2 (fi)
AT (1) ATE124991T1 (fi)
AU (1) AU623424B2 (fi)
CA (1) CA1339268C (fi)
DE (2) DE3826793A1 (fi)
ES (1) ES2076178T3 (fi)
FI (1) FI98467C (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3722968A1 (de) * 1987-07-11 1989-01-19 Behringwerke Ag Humaner papillomvirus typ 41, seine dna und die dafuer kodierenden proteine
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
WO2000061804A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
JP2005537028A (ja) * 2002-06-26 2005-12-08 ザ　ペン　ステート　リサーチ　ファウンデーション ヒト乳頭腫ウイルス感染症を治療する方法及び材料
EP1664348B8 (en) 2003-09-25 2019-06-12 Third Wave Technologies, Inc. Detection of hpv
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
AU2011258501B2 (en) 2010-05-25 2016-07-07 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337336C (en) * 1987-05-26 1995-10-17 Attila T. Lorincz Human papillomavirus nucleic acid hybridization probes and methods for employing the same

Also Published As

Publication number Publication date
US5187090A (en) 1993-02-16
EP0354440A1 (de) 1990-02-14
US6127164A (en) 2000-10-03
FI893683A (fi) 1990-02-07
EP0354440B1 (de) 1995-07-12
FI98467B (fi) 1997-03-14
AU623424B2 (en) 1992-05-14
JPH02150278A (ja) 1990-06-08
US5618694A (en) 1997-04-08
ES2076178T3 (es) 1995-11-01
DE58909339D1 (de) 1995-08-17
DE3826793A1 (de) 1990-03-08
FI98467C (fi) 1997-06-25
JP3016794B2 (ja) 2000-03-06
ATE124991T1 (de) 1995-07-15
CA1339268C (en) 1997-08-12
AU3929589A (en) 1990-02-08

Similar Documents

Publication Publication Date Title
EP0357611A4 (en) A method of detection of carcinogenic human papillomavirus
FI875082A0 (fi) Dna-sekvensser deriverade fraon genom av papillomavirus, deras anvaendning foer in vitro diagnostiska aendamaol; samt framstaellning av antigeniska kompositioner.
SI0887427T1 (sl) Pomnozevanje in detekcija HIV-1 in/ali HIV-2
CY1105963T1 (el) Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης
CA2011878A1 (en) Immunogenic regions on the e7 protein of human papillomavirus type 16
ATE241014T2 (de) Hiv-2 varianten
DK208987A (da) Polypeptider og antistoffer, som er karakteristiske for papillomvirus, og deres anvendelse ved diagnostiske metoder og i vacciner
ES2051754T3 (es) Uso de derivados cetonicos en el tratamiento de la depresion.
HUP9901035A2 (hu) Idegen DNS-t tartalmazó parapoxvírusok, előállításuk és alkalmazásuk vakcinákban
FI893683A (fi) Ihmisen papilloomavirus tyyppi 57, sen eristetty DNA ja näiden käyttö
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2112096A1 (fr) Sequences d'adn du papillomavirus hpv42 - application au diagnostic
HUP9903432A2 (hu) 19-Norkolán szteroidok mint a humán hipotalamusz működésében változást okozó neurokémiai iniciátorok
DE69736779D1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
DE3851391D1 (de) Humaner Papillomvirus Typ 41.
EP0311228A3 (en) Recombinant polypeptides and their uses, including assay for aids virus
NO874106L (no) Anioniske kopolymerer, samt fremgangsmaate for fremstilling av slike, og anvendelse av kopolymerene.
FR2580176B1 (fr) Vaccin antirabique avirulent
WO1993002217A3 (fr) Sondes oligonucleotidiques pour le typage et la detection des papillomavirus humains
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
ATE98379T1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
IT1233053B (it) Dispositivo in rotazione di rulli, particolarmente per forni di cottura di materiali ceramici ed affini.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: DADE BEHRING MARBURG GMBH

FG Patent granted

Owner name: DADE BEHRING MARBURG GMBH

MA Patent expired